Close
Digital Health & Ai Innovation summit 2026
APE 2026

Computerised physician order entry-related medication errors:

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Computerised physician order entry-related medication errors: analysis of reported errors and vulnerability testing of current systemsG D Schiff1,2, M G Amato1,3, T Eguale1,2,4, J J Boehne1, A Wright1,2, R Koppel5, A H Rashidee6, R B Elson7, D L Whitney8, T-T Thach1, D W Bates1,2,9, A C Seger1,3

1.Brigham and Women’s Hospital Division of General Medicine and Primary Care, Boston, Massachusetts, USA
2.Harvard School of Medicine, Boston, Massachusetts, USA
3.MCPHS University, Boston, Massachusetts, USA
4.McGill University, Montreal, Quebec, Canada
5.University of Pennsylvania, Philadelphia, Pennsylvania, USA
6.Quantros, San Francisco, California, USA
7.MetroHealth Center for HealthCare Research and Policy, Cleveland, Ohio, USA
8.Baylor College of Medicine, Houston, Texas, USA
9.Harvard School of Public Health, Boston, Massachusetts, USA

Correspondence to

Dr Gordon Schiff, Division of General Internal Medicine, Center for Patient Safety Research and Practice, Brigham and Women’s Hospital, 1620 Tremont St. 3rd Fl, Boston, MA 02120, USA; gschiff@partners.org

Received 8 September 2014 Revised 3 October 2014 Accepted 3 December 2014 Published Online First 16 January 2015

Abstract

Importance Medication computerised provider order entry (CPOE) has been shown to decrease errors and is being widely adopted. However, CPOE also has potential for introducing or contributing to errors.

Objectives The objectives of this study are to (a) analyse medication error reports where CPOE was reported as a ‘contributing cause’ and (b) develop ‘use cases’ based on these reports to test vulnerability of current CPOE systems to these errors.

Methods A review of medication errors reported to United States Pharmacopeia MEDMARX reporting system was made, and a taxonomy was developed for CPOE-related errors. For each error we evaluated what went wrong and why and identified potential prevention strategies and recurring error scenarios. These scenarios were then used to test vulnerability of leading CPOE systems, asking typical users to enter these erroneous orders to assess the degree to which these problematic orders could be entered.

Results Between 2003 and 2010, 1.04 million medication errors were reported to MEDMARX, of which 63 040 were reported as CPOE related. A review of 10 060 CPOE-related cases was used to derive 101 codes describing what went wrong, 67 codes describing reasons why errors occurred, 73 codes describing potential prevention strategies and 21 codes describing recurring error scenarios. Ability to enter these erroneous order scenarios was tested on 13 CPOE systems at 16 sites. Overall, 298 (79.5%) of the erroneous orders were able to be entered including 100 (28.0%) being ‘easily’ placed, another 101 (28.3%) with only minor workarounds and no warnings.

Conclusions and relevance Medication error reports provide valuable information for understanding CPOE-related errors. Reports were useful for developing taxonomy and identifying recurring errors to which current CPOE systems are vulnerable. Enhanced monitoring, reporting and testing of CPOE systems are important to improve CPOE safety.

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »